{"id":9867,"date":"2023-01-16T21:01:56","date_gmt":"2023-01-16T21:01:56","guid":{"rendered":"https:\/\/www.proveca.com\/?page_id=9867"},"modified":"2023-11-06T17:26:58","modified_gmt":"2023-11-06T17:26:58","slug":"domaines-therapeutiques","status":"publish","type":"page","link":"https:\/\/www.proveca.com\/fr\/domaines-therapeutiques\/","title":{"rendered":"Domaines th\u00e9rapeutiques"},"content":{"rendered":"\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-k7qc8ed7-159275eaa6f4c0c81e5fdd5a5a35ce23\">\n.avia-section.av-k7qc8ed7-159275eaa6f4c0c81e5fdd5a5a35ce23{\nbackground-color:#ecf2f6;\nbackground-image:url(https:\/\/www.proveca.com\/wp-content\/uploads\/2020\/03\/big-leaf-4.png);\nbackground-repeat:no-repeat;\nbackground-position:50% 50%;\nbackground-attachment:scroll;\n}\n<\/style>\n<div id='av_section_1'  class='avia-section av-k7qc8ed7-159275eaa6f4c0c81e5fdd5a5a35ce23 main_color avia-section-default avia-no-border-styling  avia-builder-el-0  el_before_av_section  avia-builder-el-first  avia-full-stretch avia-bg-style-scroll av-minimum-height av-minimum-height-custom av-height-custom  container_wrap fullsize'  data-section-bg-repeat='stretch' data-av_minimum_height_px='150'><div class='container av-section-cont-open' style='height:150px'><main  class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-9867'><div class='entry-content-wrapper clearfix'>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-k7up14rm-309c1687c14d2441696c0c2ebc6945a5\">\n.flex_column.av-k7up14rm-309c1687c14d2441696c0c2ebc6945a5{\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div  class='flex_column av-k7up14rm-309c1687c14d2441696c0c2ebc6945a5 av_one_full  avia-builder-el-1  avia-builder-el-no-sibling  first flex_column_div av-animated-generic left-to-right av-zero-column-padding  '     ><style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-k7w1jbos-ef5f006705d2de8fe1b83dbb20eb3047\">\n#top .av-special-heading.av-k7w1jbos-ef5f006705d2de8fe1b83dbb20eb3047{\npadding-bottom:10px;\ncolor:#ffffff;\n}\nbody .av-special-heading.av-k7w1jbos-ef5f006705d2de8fe1b83dbb20eb3047 .av-special-heading-tag .heading-char{\nfont-size:25px;\n}\n.av-special-heading.av-k7w1jbos-ef5f006705d2de8fe1b83dbb20eb3047 .special-heading-inner-border{\nborder-color:#ffffff;\n}\n.av-special-heading.av-k7w1jbos-ef5f006705d2de8fe1b83dbb20eb3047 .av-subheading{\nfont-size:15px;\n}\n<\/style>\n<div  class='av-special-heading av-k7w1jbos-ef5f006705d2de8fe1b83dbb20eb3047 av-special-heading-h1 custom-color-heading blockquote modern-quote  avia-builder-el-2  avia-builder-el-no-sibling '><h1 class='av-special-heading-tag '  >D\u00e9veloppement de m\u00e9dicaments p\u00e9diatriques<\/h1><div class=\"special-heading-border\"><div class=\"special-heading-inner-border\"><\/div><\/div><\/div><\/div>\n\n<\/div><\/div><\/main><!-- close content main element --><\/div><\/div><div id='av_section_2'  class='avia-section av-b8ocvq-848ec8889aa13f3b91d935de634f2344 main_color avia-section-default avia-no-border-styling  avia-builder-el-3  el_after_av_section  el_before_av_section  avia-bg-style-scroll container_wrap fullsize'  ><div class='container av-section-cont-open' ><div class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-9867'><div class='entry-content-wrapper clearfix'>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-2lzxzq-bd16d8ed8d31620fc6b177c671179e92\">\n#top .av-special-heading.av-2lzxzq-bd16d8ed8d31620fc6b177c671179e92{\npadding-bottom:10px;\n}\nbody .av-special-heading.av-2lzxzq-bd16d8ed8d31620fc6b177c671179e92 .av-special-heading-tag .heading-char{\nfont-size:25px;\n}\n.av-special-heading.av-2lzxzq-bd16d8ed8d31620fc6b177c671179e92 .av-subheading{\nfont-size:15px;\n}\n<\/style>\n<div  class='av-special-heading av-2lzxzq-bd16d8ed8d31620fc6b177c671179e92 av-special-heading-h2  avia-builder-el-4  el_before_av_two_third  avia-builder-el-first '><h2 class='av-special-heading-tag '  >Domaines th\u00e9rapeutiques<\/h2><div class=\"special-heading-border\"><div class=\"special-heading-inner-border\"><\/div><\/div><\/div>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-93zaqe-6719ee2ffeb09ccf52b7dfa3fafcda10\">\n.flex_column.av-93zaqe-6719ee2ffeb09ccf52b7dfa3fafcda10{\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div  class='flex_column av-93zaqe-6719ee2ffeb09ccf52b7dfa3fafcda10 av_two_third  avia-builder-el-5  el_after_av_heading  el_before_av_one_third  first flex_column_div av-zero-column-padding  '     ><section  class='av_textblock_section av-k6t9u9qf-8aa8302f23db86c480899c894fe2b675 '  ><div class='avia_textblock' ><p>Selon l&rsquo;Acad\u00e9mie de Pharamacie Fran\u00e7aise, une grande partie des m\u00e9dicaments utilis\u00e9s en p\u00e9diatrie (de 11 % \u00e0 80 %) en France sont prescrits en dehors du cadre de l\u2019autorisation de mise sur le march\u00e9 (AMM), c&rsquo;est-\u00e0-dire dans une indication, une posologie, avec une forme gal\u00e9nique ou \u00e0 un \u00e2ge diff\u00e9rent de ceux pr\u00e9cis\u00e9s dans l&rsquo;AMM, en extrapolant \u00e0 partir des donn\u00e9es disponibles chez l\u2019adulte, et sans que des essais cliniques sp\u00e9cifiques chez l\u2019enfant aient \u00e9t\u00e9 conduits. Les m\u00e9dicaments avec une AMM p\u00e9diatrique ne sont donc pas courants et r\u00e9pondent \u00e0 un besoin m\u00e9dical important non satisfait.\u00b9<\/p>\n<p>En 2007, les r\u00e9gulateurs europ\u00e9ens ont lanc\u00e9 des initiatives visant \u00e0 inciter les entreprises \u00e0 d\u00e9velopper des m\u00e9dicaments p\u00e9diatriques avec des mol\u00e9cules \u00e9prouv\u00e9es qui ne sont plus couvertes par un brevet. La plus importante de ces initiatives a \u00e9t\u00e9 le processus d\u2019homologation PUMA (Paediatric Use Marketing Authorisation). Proveca a collabor\u00e9 avec le comit\u00e9 p\u00e9diatrique de l\u2019EMA pour obtenir une AMM dite PUMA.<\/p>\n<p>Ce type d\u2019autorisation de mise sur le march\u00e9 implique une indication et une formulation appropri\u00e9es pour les enfants. Les exigences de d\u00e9veloppement du m\u00e9dicament p\u00e9diatrique sont-elles d\u00e9finies dans un PIP (plan d\u2019investigation p\u00e9diatrique) approuv\u00e9 pr\u00e9alablement \u00e0 l&rsquo;AMM.<\/p>\n<p>Les m\u00e9dicaments p\u00e9diatriques du pipeline de Proveca sont d\u00e9velopp\u00e9 par le biais d\u2019un processus structur\u00e9 d\u2019identification et d\u2019\u00e9valuation. Chaque \u00ab\u00a0candidat m\u00e9dicament\u00a0\u00bb est \u00e9valu\u00e9 en fonction d\u2019un certain nombre de facteurs cl\u00e9s afin de permettre le d\u00e9veloppement d&rsquo;une forme p\u00e9diatrique.<\/p>\n<p>Le processus comprend l\u2019identification du \u00ab\u00a0candidat\u00a0\u00bb et son \u00e9valuation technique, r\u00e9glementaire et commerciale. Les candidats m\u00e9dicaments appropri\u00e9s sont ensuite soumis au processus r\u00e9glementaire PIP\/PUMA afin d\u2019obtenir une AMM p\u00e9diatrique europ\u00e9enne.<\/p>\n<p>La Recherche et d\u00e9veloppement (R&amp;D) de Proveca se concentre sur les m\u00e9dicaments p\u00e9diatriques \u00a0pour le traitement de sympt\u00f4mes li\u00e9s \u00e0 la paralysie c\u00e9r\u00e9brale, \u00a0contre l\u2019\u00e9pilepsie et de l\u2019insuffisance cardiaque.<\/p>\n<ol>\n<li>ACAD\u00c9MIE NATIONALE DE PHARMACIE, Recommandations m\u00e9dicaments p\u00e9diatriques VF 13.06.2012<\/li>\n<\/ol>\n<\/div><\/section><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-7cemra-81e5828bbb92af2338ddd0a537c6d1c3\">\n.flex_column.av-7cemra-81e5828bbb92af2338ddd0a537c6d1c3{\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div  class='flex_column av-7cemra-81e5828bbb92af2338ddd0a537c6d1c3 av_one_third  avia-builder-el-7  el_after_av_two_third  avia-builder-el-last  flex_column_div av-zero-column-padding  '     ><style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-k8503lxo-f2442181b030e99a36487e2c96c868e9\">\n.avia-image-container.av-k8503lxo-f2442181b030e99a36487e2c96c868e9 img.avia_image{\nbox-shadow:none;\n}\n.avia-image-container.av-k8503lxo-f2442181b030e99a36487e2c96c868e9 .av-image-caption-overlay-center{\ncolor:#ffffff;\n}\n<\/style>\n<div  class='avia-image-container av-k8503lxo-f2442181b030e99a36487e2c96c868e9 av-styling-no-styling avia_animated_image av-animated-when-visible-95 fade-in avia-align-center  avia-builder-el-8  avia-builder-el-no-sibling '  ><div class=\"avia-image-container-inner\"><div class=\"avia-image-overlay-wrap\"><img decoding=\"async\" fetchpriority=\"high\" class='wp-image-9870 avia-img-lazy-loading-not-9870 avia_image ' src=\"https:\/\/www.proveca.com\/wp-content\/uploads\/2020\/03\/child_teddy_bear3.jpg\" alt='' title='child_teddy_bear3'  height=\"463\" width=\"498\" srcset=\"https:\/\/www.proveca.com\/wp-content\/uploads\/2020\/03\/child_teddy_bear3.jpg 498w, https:\/\/www.proveca.com\/wp-content\/uploads\/2020\/03\/child_teddy_bear3-300x279.jpg 300w\" sizes=\"(max-width: 498px) 100vw, 498px\" \/><\/div><\/div><\/div><\/div><\/div><\/div><\/div><!-- close content main div --><\/div><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-7vg2om-baa2067e1d9622bfe7a5a34ccb03421e\">\n.avia-section.av-7vg2om-baa2067e1d9622bfe7a5a34ccb03421e{\nbackground-color:#009fe3;\nbackground-image:unset;\n}\n<\/style>\n<div id='av_section_3'  class='avia-section av-7vg2om-baa2067e1d9622bfe7a5a34ccb03421e main_color avia-section-default avia-no-shadow  avia-builder-el-9  el_after_av_section  avia-builder-el-last  avia-bg-style-scroll container_wrap fullsize'  ><div class='container av-section-cont-open' ><div class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-9867'><div class='entry-content-wrapper clearfix'>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-k7xgzw3q-bc3a002455c21b744ebc864c68741ffb\">\n#top .av-special-heading.av-k7xgzw3q-bc3a002455c21b744ebc864c68741ffb{\npadding-bottom:10px;\ncolor:#ecf2f6;\nfont-size:35px;\n}\nbody .av-special-heading.av-k7xgzw3q-bc3a002455c21b744ebc864c68741ffb .av-special-heading-tag .heading-char{\nfont-size:25px;\n}\n#top #wrap_all .av-special-heading.av-k7xgzw3q-bc3a002455c21b744ebc864c68741ffb .av-special-heading-tag{\nfont-size:35px;\n}\n.av-special-heading.av-k7xgzw3q-bc3a002455c21b744ebc864c68741ffb .special-heading-inner-border{\nborder-color:#ecf2f6;\n}\n.av-special-heading.av-k7xgzw3q-bc3a002455c21b744ebc864c68741ffb .av-subheading{\nfont-size:15px;\n}\n\n@media only screen and (min-width: 480px) and (max-width: 767px){ \n#top #wrap_all .av-special-heading.av-k7xgzw3q-bc3a002455c21b744ebc864c68741ffb .av-special-heading-tag{\nfont-size:0.8em;\n}\n}\n\n@media only screen and (max-width: 479px){ \n#top #wrap_all .av-special-heading.av-k7xgzw3q-bc3a002455c21b744ebc864c68741ffb .av-special-heading-tag{\nfont-size:0.8em;\n}\n}\n<\/style>\n<div  class='av-special-heading av-k7xgzw3q-bc3a002455c21b744ebc864c68741ffb av-special-heading-h2 custom-color-heading blockquote modern-quote modern-centered  avia-builder-el-10  avia-builder-el-no-sibling  av-inherit-size'><h2 class='av-special-heading-tag '  >Nous sommes soucieux des m\u00e9dicaments destin\u00e9s \u00e0 vos enfants<\/h2><div class=\"special-heading-border\"><div class=\"special-heading-inner-border\"><\/div><\/div><\/div>\n<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-9867","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>M\u00e9dicaments p\u00e9diatriques : paralysie c\u00e9r\u00e9brale, \u00e9pilepsie et insuffisance cardiaque<\/title>\n<meta name=\"description\" content=\"Proveca se concentre sur le d\u00e9veloppement de m\u00e9dicaments p\u00e9diatriques dans les domaines therapeutiques de la paralysie c\u00e9r\u00e9brale, l\u2019\u00e9pilepsie et l\u2019insuffisance cardiaque infantile. En savoir plus sur nos domaines th\u00e9rapeutiques et notre pipeline de produits.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.proveca.com\/fr\/domaines-therapeutiques\/\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"M\u00e9dicaments p\u00e9diatriques : paralysie c\u00e9r\u00e9brale, \u00e9pilepsie et insuffisance cardiaque\" \/>\n<meta property=\"og:description\" content=\"Proveca se concentre sur le d\u00e9veloppement de m\u00e9dicaments p\u00e9diatriques dans les domaines therapeutiques de la paralysie c\u00e9r\u00e9brale, l\u2019\u00e9pilepsie et l\u2019insuffisance cardiaque infantile. En savoir plus sur nos domaines th\u00e9rapeutiques et notre pipeline de produits.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.proveca.com\/fr\/domaines-therapeutiques\/\" \/>\n<meta property=\"og:site_name\" content=\"Proveca\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-06T17:26:58+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.proveca.com\\\/fr\\\/domaines-therapeutiques\\\/\",\"url\":\"https:\\\/\\\/www.proveca.com\\\/fr\\\/domaines-therapeutiques\\\/\",\"name\":\"M\u00e9dicaments p\u00e9diatriques : paralysie c\u00e9r\u00e9brale, \u00e9pilepsie et insuffisance cardiaque\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.proveca.com\\\/fr\\\/#website\"},\"datePublished\":\"2023-01-16T21:01:56+00:00\",\"dateModified\":\"2023-11-06T17:26:58+00:00\",\"description\":\"Proveca se concentre sur le d\u00e9veloppement de m\u00e9dicaments p\u00e9diatriques dans les domaines therapeutiques de la paralysie c\u00e9r\u00e9brale, l\u2019\u00e9pilepsie et l\u2019insuffisance cardiaque infantile. En savoir plus sur nos domaines th\u00e9rapeutiques et notre pipeline de produits.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.proveca.com\\\/fr\\\/domaines-therapeutiques\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.proveca.com\\\/fr\\\/domaines-therapeutiques\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.proveca.com\\\/fr\\\/domaines-therapeutiques\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.proveca.com\\\/fr\\\/homepage-2\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Domaines th\u00e9rapeutiques\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.proveca.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.proveca.com\\\/fr\\\/\",\"name\":\"Proveca\",\"description\":\"Medicines for children\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.proveca.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"M\u00e9dicaments p\u00e9diatriques : paralysie c\u00e9r\u00e9brale, \u00e9pilepsie et insuffisance cardiaque","description":"Proveca se concentre sur le d\u00e9veloppement de m\u00e9dicaments p\u00e9diatriques dans les domaines therapeutiques de la paralysie c\u00e9r\u00e9brale, l\u2019\u00e9pilepsie et l\u2019insuffisance cardiaque infantile. En savoir plus sur nos domaines th\u00e9rapeutiques et notre pipeline de produits.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.proveca.com\/fr\/domaines-therapeutiques\/","og_type":"article","og_title":"M\u00e9dicaments p\u00e9diatriques : paralysie c\u00e9r\u00e9brale, \u00e9pilepsie et insuffisance cardiaque","og_description":"Proveca se concentre sur le d\u00e9veloppement de m\u00e9dicaments p\u00e9diatriques dans les domaines therapeutiques de la paralysie c\u00e9r\u00e9brale, l\u2019\u00e9pilepsie et l\u2019insuffisance cardiaque infantile. En savoir plus sur nos domaines th\u00e9rapeutiques et notre pipeline de produits.","og_url":"https:\/\/www.proveca.com\/fr\/domaines-therapeutiques\/","og_site_name":"Proveca","article_modified_time":"2023-11-06T17:26:58+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.proveca.com\/fr\/domaines-therapeutiques\/","url":"https:\/\/www.proveca.com\/fr\/domaines-therapeutiques\/","name":"M\u00e9dicaments p\u00e9diatriques : paralysie c\u00e9r\u00e9brale, \u00e9pilepsie et insuffisance cardiaque","isPartOf":{"@id":"https:\/\/www.proveca.com\/fr\/#website"},"datePublished":"2023-01-16T21:01:56+00:00","dateModified":"2023-11-06T17:26:58+00:00","description":"Proveca se concentre sur le d\u00e9veloppement de m\u00e9dicaments p\u00e9diatriques dans les domaines therapeutiques de la paralysie c\u00e9r\u00e9brale, l\u2019\u00e9pilepsie et l\u2019insuffisance cardiaque infantile. En savoir plus sur nos domaines th\u00e9rapeutiques et notre pipeline de produits.","breadcrumb":{"@id":"https:\/\/www.proveca.com\/fr\/domaines-therapeutiques\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.proveca.com\/fr\/domaines-therapeutiques\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.proveca.com\/fr\/domaines-therapeutiques\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.proveca.com\/fr\/homepage-2\/"},{"@type":"ListItem","position":2,"name":"Domaines th\u00e9rapeutiques"}]},{"@type":"WebSite","@id":"https:\/\/www.proveca.com\/fr\/#website","url":"https:\/\/www.proveca.com\/fr\/","name":"Proveca","description":"Medicines for children","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.proveca.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.proveca.com\/fr\/wp-json\/wp\/v2\/pages\/9867","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.proveca.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.proveca.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.proveca.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.proveca.com\/fr\/wp-json\/wp\/v2\/comments?post=9867"}],"version-history":[{"count":3,"href":"https:\/\/www.proveca.com\/fr\/wp-json\/wp\/v2\/pages\/9867\/revisions"}],"predecessor-version":[{"id":16132,"href":"https:\/\/www.proveca.com\/fr\/wp-json\/wp\/v2\/pages\/9867\/revisions\/16132"}],"wp:attachment":[{"href":"https:\/\/www.proveca.com\/fr\/wp-json\/wp\/v2\/media?parent=9867"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}